9
Participants
Start Date
January 10, 2023
Primary Completion Date
October 30, 2024
Study Completion Date
October 30, 2028
HG004
Method of Administration: Once unilateralsubretinal injection; The duration of the study isabout 60 weeks for each subject including a 8-weekscreening period, enrollment/baseline visit,treatment visit, and 52 weeks follow-up period.
Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySchool of Medicine, Shanghai
Collaborators (1)
HuidaGene Therapeutics Co., Ltd.
INDUSTRY
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER